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Abstract
Background: Telepathology may play an important role in pathology consultation and quality control for cancer
diagnosis in China, as the country has the largest population of cancer patients worldwide. In 2011, the Pathology
Quality Control Center of China and Ministry of Health developed and implemented a nationwide telepathology
consultation and quality control program for cancer diagnosis in China. We here report the results of the two-year
implementation and experiences.
Methods: The program built an Internet based telepathology platform to connect participating hospitals and
expert consultants. The hardware and software used for the platform were validated in previous validation studies
in China. The program had three regional centers consisting of Peking Union Medical College, Huasi Medical
College of Sichuan and 2nd affiliated hospital of Zhejiang University. It also had 20 provincial consultation centers
based in the provincial referral hospitals. 80 provincial or national pathologists served as expert consultants for the
program, providing telepathology consultation for cancer diagnosis for more than 60 participating hospitals.
Results: From 2011 to July 2013, 16,247 pathology cases were submitted to the platform for consultation. Among
them, 84% were due to diagnostic difficulty and 16% were due to request by patients. The preliminary diagnosis
provided by submitting pathologists were in agreement with expert opinion in 59.8% of cases but was in
disagreement with expert opinion in 24.2% of cases. 16.0% of cases were not provided with preliminary diagnosis.
The distribution of pathology cases by system or organ were: digestive system, 17.3%; gynecologic system, 16.7%;
head and neck, 15.7%; bone and soft tissue, 10.4%; lung and mediastinum, 8.6%; breast, 7.6%; urinary system, 7.5%;
hematopathology, 6.4%; skin, 5.2%; neuropathology, 2.5% and cytopathology, 1.3%. Expert consultants also provided
assessment of quality of slide preparation and staining, online lectures and guidance for pathology quality control.
Conclusion: Our results of two years’ implementation indicated that telepathology could solve the problem of
uneven distribution of pathology resources and provide a solution for countrywide pathology quality control in
China. Telepathology could play an important role in improving pathology diagnosis in China.
Background
WHO estimated that China had 2.80 million newly diag-
nosed cancer patients in 2008 [1]. According to National
Health and Family Planning Commission of China,
cancer is the No.1 cause of death in China, accounting
for 1.96 million deaths annually. As the most populous
country in the world with a population exceeding
1.37 billion, China has the largest number of cancer
patients worldwide. In addition, its population is rapidly
aging. As the number of newly diagnosed cancer patient
in China has been increasing rapidly, cancer diagnosis
and treatment are becoming an important part of health
care in China.
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Accuracy of pathology diagnosis plays a key role in the
effective management of cancer patients. China however,
has limited pathology resources. The country has limited
numbers of well-trained and experienced pathologists;
most of them work in large teaching hospitals in big cities.
A recent survey by Chinese Pathologists Association
showed that a majority of pathologists in clinical practice
in China had only one year of formal training. Pathology
residency programs similar to those of Western countries
are only available since 2010 and are limited in a couple of
large medical schools. Most pathologists and even pathol-
ogists in large tertiary teaching hospitals or provincial
referral hospitals are not sub-specialized. Pathologists in
community hospitals often have difficulty in diagnosing
rare or complex cancer pathology cases. Error in pathology
diagnosis is not uncommon, which often results in medical
legal problem. There is an urgent need for pathology con-
sultation and pathology quality control in China.
Telepathology is the practice of pathology by interpret-
ing digitalized images or whole slide images (WSI) by
pathologists at a long distance. It could be applied in
many areas of pathology practice, including remote con-
sultation, quality control, teaching and continuing medical
education [2,3]. Telepathology offers the efficient utiliza-
tion of subspecialty pathologists to solve problems of
shortage of pathologists and subspecialists at remote sites
or remote hospitals [4]. In order to improve the quality of
pathology diagnosis by using limited pathology resources,
the Pathology Quality Control Center of China, under the
guidance of National Health and Family Planning Com-
mission, developed and implemented a nationwide tele-
pathology consultation and quality control program for
cancer diagnosis in China in 2011. We here report the
results of the implementation and two-years operation of
the program.
Methods
Internet platform and network
A website based telepathology consultation platform
www.mpathology.cn was developed to provide connec-
tions for hospitals and expert consultants. An Internet
based platform could be accessed by multiple hospitals/
institutions and by expert pathologists from different
institutions. The program has three regional centers
based in Peking Union Medical College, Beijing, Huasi
Medical College of Sichuan, and 2nd affiliated hospital of
Zhejiang University respectively, and 20 provincial cen-
ters based in their respective provincial referral hospitals.
Pathologists from community hospitals sent digital
images or WSI of the histology slides of cancer through
the internet to the server of the platform to be stored in
the server; expert pathologists from different institutions
could access the website through the internet, review the
WSI stored in the server, make a pathology diagnosis or
offer a second opinion, and assess the quality of pathol-
ogy slides and pathology diagnosis from submitting
hospitals.
For telepathology consultation, the following steps are
involved: pathologists from community hospitals sent con-
sultation requests accompanied by attached WSI and rele-
vant clinical information to the platform, the system alerts
its technician by e-mails; the technician checks the sub-
mitted materials for the name of the expert pathologist
being requested for consultation and completeness of the
submitted images and clinical information; the system
manager contacts the expert pathologist by cell phone
message and email, informing him or her of pending con-
sultation case. The expert pathologist logs into the website
by a computer or an Ipad; checks out the pending cases
for consultation under his/her name; review pathology of
the WSI; captures a representative image from WSI to
included in the final report; and enters the pathology diag-
nosis. Once the expert pathologist releases the final report,
the system automatically informs its technician who then
sends pathology consultation report to submitting pathol-
ogist by email and regular mail.
For quality control, expert pathologists logged into the
website to assess the accuracy of pathology diagnosis and
quality of histology slides of specific hospitals. The results
of the assessment were sent to provincial and national
pathology quality control centers.
All participating hospitals were equipped with a virtual
microscope (Motic Medical Diagnostic System, China).
The microscope and its software were designed to scan
histology glass slides, generate and integrate digital
images into a whole slide image (WSI). A WSI of an H/E
tissue slide under x20 objective (0.47 µm/pixel) could be
completed within 3 minutes. The WSI could be viewed
as if it is a tissue slide under a microscope with 2×, 4×,
10×, 20× and 40× objectives. The virtual microscope and
related software were tested and validated in a previous
study of a variety of 600 surgical pathology specimens in
China. The study showed a high concordance rate
(94.2%) between WSI and H/E glass slide [5,6].
Expert consultants and hospitals
All of the 80 expert pathologists were selected from 356
pathologists, who had provincial and national reputations
and volunteered to participate in the project. The patholo-
gists took an online assessment of 30 pathology consulta-
tion cases in WSI format. Based on the assessment result,
80 pathologists were selected as expert consultants for the
program. The names, location and expertise of the pathol-
ogists were listed on the website www.mpathology.cn.
60 out of 87 hospitals in 20 provinces were selected for
the program. Pathologists from the hospitals took an
online diagnostic test consisting of 50 pathology cases.
Those hospitals having pathologists with poor test results
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were included in the program. All of the participating
hospitals have more than 6000 surgical pathology cases
annually.
Training and quality controls
In September 2011, expert pathologists in three regional
centers held a short-term training session for pathologists
and laboratory technologists from 57 participating hospi-
tals. The training included tissue grossing and processing,
preparation of H/E histology slide, digital scanning of his-
tologic slide, and application of telepathology software to
create WSI, manage case files, connect to the website of
the platform. Privacy policy and secure storage of the WSI
and teleconsultation reports were emphasized. In March,
August and October 2012, expert pathologists inspected
22 participating hospitals in three separate visits, providing
onsite assessment and guidance to improve the accuracy
and quality of pathology diagnosis of the hospitals.
Results
Figure 1 shows that the number of pathology consulta-
tion cases sent to the program increased significantly
from 2011 to 2013. From the inception of the program
to July 2013, a total of 16,247 pathology cases were sent
to the platform for consultation. Among them, 84%
were cases with diagnostic difficulty; 16% were consulta-
tion requested by the patients. Hospitals located in
urban areas sent in 12,510 cases, accounting for 77% of
cases. Hospitals located in county or rural areas sent in
3,737 cases, accounting for 23% of cases.
Table 1 shows the turn-around time for pathology
consultation in the telepathology platform. 87% cases
had consultation reports released within 48 hours, and
61.5% cases had consultation reports released within
24 hours.
Figure 2 shows the agreement of diagnosis between
expert consultants and submitting community patholo-
gists. Expert consultants agreed with preliminary diag-
nosis in 59.8% of cases but disagreed with preliminary
diagnosis in 24.2% of cases. Submitting pathologists did
not provide preliminary diagnosis for 16% of cases.
Table 2 shows the distribution of consultation cases
among different body system and organs: digestive sys-
tem, 17.3%; gynecologic system, 16.7%; head and neck,
15.7%; bone and soft tissue, 10.4%; lung and mediasti-
num, 8.6%; breast, 7.6%; urinary system, 7.5%; hemato-
pathology, 6.4%; skin, 5.2%; neuropathology, 2.5% and
cytopathology, 1.3%.
Discussion
In recent years, telepathology has been applied successfully
in remote pathology consultation and in quality control
[2,7]. Since 2009, because of the availability of high speed
Internet, 3G wireless networks and low cost “made in
China” commercial virtual microscopes, telepathology has
become the focus of attention among pathology commu-
nity in China. A validation study of telepathology consulta-
tion in China showed that the mean accuracy of pathology
diagnosis using virtual image is 94.2% as compared to H/E
glass slide [5]. In 2010, Ministry of Health of China
released an announcement to promote telepathology for
cancer diagnosis in China and initiated a plan to build a
nationwide telepathology consultation and quality control
Figure 1 Numbers of consultation cases in different years.
Table 1 Turn around time of the teleconsultation
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network. The goal is to provide telepathology consultation
and to monitor the accuracy of pathology diagnosis of can-
cer in China. The program called for provinces to develop
their own provincial telepathology consultation and quality
control centers, each of them then connected to national
center. By 2011, a website based consultation and quality
control platform were implemented to connect a network
of 60 hospitals from 20 provinces.
The results of the two-year experience and implemen-
tation showed that the number of consultation cases sub-
mitted to the platform increased quickly. Within one and
half year, a total number of 16,247 cases have been
reached. Most of the cases were diagnostic challenging
cases. More cases were sent by hospitals from urban
areas as compared with hospital from county/rural areas.
The reason may be due to that hospitals in urban areas
have more surgical pathology specimens and more
pathology cases with diagnostic complexity as compared
to county/rural areas. Another reason is that the patholo-
gists and patients in urban hospitals were better informed
about telepathology consultation platform than those in
county/rural hospitals. Our results indicated that tele-
pathology could play a role in cancer pathology diagnosis
in both county/rural hospitals and city hospitals.
Analysis of the turn-around time of telepathology con-
sultation showed that almost all of our consultation
reports were released within 48 hours. Our turn around
time is much shorter than the 7 average days of turn
around time of conventional pathology consultation
reported in US where glass slides were used [8]. A shorter
turn-around time for cancer diagnosis reduces the anxiety
of patients and increases the chance for immediate treat-
ment. In view of turn-around time, consultation provided
by telepathology has great advantage over conventional
pathology consultation.
Pathology consultation or second opinion in pathology
diagnosis plays a pivotal role in cancer diagnosis [9,10].
Several reports from North America showed that the dis-
agreement in pathology diagnosis between expert consul-
tants and submitting pathologists were around 10%
[11,12]. The disagreement in diagnosis for lymphoma
was as high as 16.4% [13]. Among Asian countries, the
rate of disagreement in pathology diagnosis between
expert pathologists and submitting pathologists is much
higher, ranging from 16% to 64.3% [14,15]. An analysis of
673 consultation cases sent to Twain Cancer Center
showed that 16% of the cases had second opinion signifi-
cantly differ from primary diagnosis [14]. Hsu et al
reported that, among 2,686 consultation cases, 64.3% of
cases had expert opinion different from preliminary diag-
nosis and 205 cases (12.3%) showed significant disagree-
ment [15]. Our result of 16,247 teleconsultation cases
showed that 24.2% (3,932 cases) of cases had experts’ opi-
nion significantly different from submitting pathologists.
The significant difference means a change from malig-
nant to benign or from benign to malignant. The rate
increases to 28.8% (3,932 out of 13,647 cases) if cases
without preliminary diagnosis were excluded from analy-
sis. Our result is significantly high than those reported in
North America and Twain but lower than those reported
in other Asia countries or region. In addition, 16% of our
cases were received without a preliminary diagnosis pro-
vided by community pathologists, which indicated that
40.2% of our cases benefit from telepathology consulta-
tion. Our results indicated that telepathology is very valu-
able in cancer diagnosis in China.
Due to the differences in cancer types and in biopsy
rate, the distribution of consultation cases among differ-
ent body organs and systems may be different between
Western countries and China. Our results showed that in
China, most of the consultation cases were from gastro-
intestinal tract/live and pancreas, gynecology, head and
neck, bone and soft tissue, and respiratory system. Unlike
Western countries, skin pathology, hematopathology and
Figure 2 Agreement of pathologic diagnosis between expert
consultants and submitting pathologists.
Table 2 Distribution of consultation cases among
different body organs and systems
Body system Percent (%)
Digestive, liver and pancreas 17.3
Gynecologic 16.7
Head and neck 15.7
Bone and soft tissue 10.4
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cytopathology accounted for low percentage of the con-
sultation cases in China [10]. The difference in distribu-
tion of teleconsultation cases may provide guidance for
training of subspecialty pathologists in China.
From May 2012, the program provided more than 40
Internet based pathology lectures by expert consultants.
The lectures are free and open to all pathologists in the
country. The result indicated that the platform could also
play a role in providing continuing medical education for
pathologists nationwide.
In future, telepathology or digital pathology will play a
key role in pathology diagnosis and quality control, as its
current development is accelerate by the advance of digital
and internet technology, and is supported by the govern-
ment. Telepathology is also cost effective and could play a
role in health care reform. Telepathology consultation aids
pathologists to diagnose difficult pathology cases, reduces
errors in diagnosis and avoids unnecessary medical legal
expenses; telepathology also benefits patients who no
longer need to travel to large hospitals for a second opi-
nion for cancer diagnosis, thus saving time and money for
patients. We believe that in near future telepathology will
become an important part of telemedicine and will play a
role in health care reform in China.
Conclusion
We reported the implementation of a nationwide tele-
pathology consultation platform in China and analyze the
results of its two-year operation. An internet based tele-
pathology open platform was established to connect 60
participating hospitals and 80 pathology experts. Our two-
years results indicated that 16, 247 pathology cases were
sent to the platform over one and half years. Telepathol-
ogy provided a fast consultation service with a turn around
time less than 48 hours and improved cancer pathology
diagnosis in about 40% of cases submitted for consulta-
tion. Telepathology could play an important role in
improving quality of cancer diagnosis and in solving a
shortage of pathology resource in China.
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